Viewing Study NCT02997800



Ignite Creation Date: 2024-05-06 @ 9:30 AM
Last Modification Date: 2024-10-26 @ 12:15 PM
Study NCT ID: NCT02997800
Status: COMPLETED
Last Update Posted: 2020-02-13
First Post: 2016-12-08

Brief Title: The Effect of Intraoperative Labetalol on Time to Discharge
Sponsor: Dr Robert Tanzola
Organization: Queens University

Study Overview

Official Title: The Effect of Intraoperative Labetalol on Time to Discharge and Hemodynamic Stability in Laparoscopic Cholecystectomy
Status: COMPLETED
Status Verified Date: 2020-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients coming for surgery often receive opioid medications like fentanyl to treat pain Opioids however have many unpleasant side effects including nausea and vomiting itching sedation and decreased breathing During laparoscopic surgery increases in heart and blood pressure are often attributed to pain It has been shown that by treating these changes with medications such as esmolol instead of opioids side effects and time to discharge from hospital can be reduced Labetalol is a drug that is similar to esmolol but may have advantages over it It is more effective at controlling both heart rate and blood pressure and it is easier and less costly to use This study is investigating labetalol in patients having laparoscopic gallbladder surgery and comparing it to esmolol and fentanyl Patients will be treated with one of these drugs during surgery to control heart rate and blood pressure and the effects on time to discharge pain scores frequency of side effects and narcotic requirements will be observed in the recovery room It is thought that labetalol will be shown to be as effective as esmolol and that both drugs that minimize fentanyl will show reduced time to discharge fewer side effects and effective treatment of heart rate and blood pressure
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None